SCHEMBL8530371

SCHEMBL8530371

CCCCC(=O)O[C@H]1[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]1n1cnc2c(OC)nc(N)nc21

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HINT1 P49773 2/20 0.40
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SLC29A1 Q99808 3/20 0.37
ADORA2B P29275 5/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA1 P30542 2/20 0.36
NT5E P21589 1/20 0.36
HSP90B1 P14625 1/20 0.35
ADORA2A P29274 3/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8529436 0.89 ALDH1A1 (0.48) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8529887 0.88 HINT1 (0.40) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8533343 0.87 HINT1 (0.40) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8530373 0.87 ADORA2A (0.40) HINT1SLC29A1ADORA2BADORA1NT5E
SCHEMBL8533171 0.85 HINT1 (0.40) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8530375 0.85 P2RX3 (0.46) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8529155 0.85 ALDH1A1 (0.52) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8529223 0.83 HINT1 (0.45) HINT1SLC29A1ADORA2BADORA3ADORA1
SCHEMBL8528882 0.83 HINT1 (0.45) HINT1SLC29A1ADORA2BADORA3ADORA1
SCHEMBL8988189 0.83 HINT1 (0.38) HINT1ALDH1A1LMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821236-A Tumor treatment with arabinofuranosyl purine derivatives GLAXO WELLCOME INC. (US) 1998-10-13 US disclosed
US-5747472-A ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. (US) 1998-05-05 US disclosed
US-5492897-A ANTITUMOR AGENTS, AUTOIMMUNE DISEASES BURROUGHS WELLCOME CO. (141) (US) 1996-02-20 US disclosed
US-5424295-A Useful in treatment of varicella-zoster virus infections BURROUGHS WELLCOME CO. (US) 1995-06-13 US disclosed
WO-1992001456-A1 HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1992-02-06 WO disclosed